Clinical Significance of CBC and WBC Morphology in the Diagnosis and Clinical Course of COVID-19 Infection 


Olga Pozdnyakova, MD, PhD, Nathan T Connell, MD, MPH, Elisabeth M Battinelli, MD, PhD, Jean M Connors, MD, Geoffrey Fell, MS, Annette S Kim, MD, PhD, American Journal of Clinical Pathology, Volume 155, Issue 3, March 2021, Pages 364–375, https://doi.org/10.1093/ajcp/aqaa231 Abstract Objectives To investigate the clinical significance of numeric and morphologic peripheral blood (PB) changes in coronavirus disease 2019 (COVID-19)–positive patients […]

Hematological alterations associated with long COVID-19


Guilherme C. Lechuga1,2,3Carlos M. Morel1Salvatore Giovanni De-Simone1,2,4*, Front. Physiol., 23 July 2023Sec. Red Blood Cell Physiology, Volume 14 – 2023 | https://doi.org/10.3389/fphys.2023.1203472 Long COVID-19 is a condition characterized by persistent symptoms lasting beyond the acute phase of COVID-19. Long COVID-19 produces diverse symptomatology and can impact organs and systems, including the hematological system. Several studies have […]

UCSF Researchers Identify Major Driver Behind COVID And Long COVID, With Potential Treatment


Authored by Marina Zhang via The Epoch Times Researchers at the University of California San Francisco have identified fibrin, a natural protein involved in blood clotting, as a major driver of the COVID-19 disease, according to a new study. Fibrin binds to proteins from the SARS-CoV-2 virus to form blood clots that are difficult to break down, the […]

Superior Mesenteric Artery Thrombosis in COVID-19-Positive Patients: A Rare Coincidence


Rushabh Parekh • Virendra Athavale • Saili Kelshikar, : June 11, 2024, DOI: 10.7759/cureus.62136  Abstract Since the start of the SARS-CoV-2 pandemic, which is otherwise known as the worldwide coronavirus disease, 2019, has had a well-established pro-thrombotic character. Patients often first exhibit respiratory symptoms, and those whose severity increases eventually develop acute hypoxic respiratory failure. The systemic hypercoagulable condition and arterial/venous […]

Platelet Indices as Novel Surrogate Markers for the Prognosis of COVID-19 Infection: An Observational Study


Vivek Lahane • Sourya Acharya • Samarth Shukla • et. al. June 12, 2024 DOI: 10.7759/cureus.62243  Abstract Background  The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes severe acute respiratory illness accountable for causing the coronavirus disease 2019 (COVID-19) illness. Thrombotic issues, acute respiratory distress syndrome (ARDS), and cytokine storm are significant contributors to morbidity and mortality in patients with COVID-19. Elevated D-dimer […]

The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches


Roxana Gheorghita1,2Iuliana Soldanescu3Andrei Lobiuc, et. al. , Frontiers in Medicine The coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 has been defined as the greatest global health and socioeconomic crisis of modern times. While most people recover after being infected with the virus, a significant proportion of them continue to experience health issues weeks, months […]

Scientists Decode Deadly Blood Clot Disorder Triggered by COVID Vaccines


By FLINDERS UNIVERSITY MAY 26, 2024 Researchers from Flinders University, along with international experts, have discovered that the PF4 antibodies causing VITT after adenovirus vector-based COVID-19 vaccination share identical molecular signatures with those found in similar cases following natural adenovirus infection. This finding, using a new approach developed at Flinders, has significant implications for understanding the genetic […]

AstraZeneca admits to rare, deadly side effect of COVID jab as lawsuits mount


By Chris Nesi,  April 29, 2024, NY Post AstraZeneca has admitted that its COVID-19 vaccine could cause a rare but deadly blood-clotting condition, potentially exposing the UK pharmaceutical giant to tens of millions in lawsuits brought by loved ones of those injured or killed as a result of the jab, according to court documents. Lawyers representing […]

Long Covid explanation in new study possibly paves way for tests and treatments


Scientists say that drugs that calm a key part of the immune system should be studied in clinical trials as potential long Covid treatments. Long Covid impacts some adults’ blood biomarkers, new study finds Jan. 18, 2024, By Barbara Mantel, Science Scientists have identified a persistent change in a handful of blood proteins in people with […]

COVID Vaccines Could Trigger Vasculitis, Damaging Multiple Organs


Several case reports indicate the COVID vaccines may be associated with vasculitis, a condition that inflames and damages blood vessels. By Ellen Wan, 2024 The Epochtimes Various diseases associated with COVID-19 vaccines have been reported. A recent case study indicated that COVID-19 vaccination may trigger the development of anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis, potentially damaging multiple organs. […]